Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine (98 page)

BOOK: Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine
2.46Mb size Format: txt, pdf, ePub

Nonaldosterone mineralocorticoid excess
mimics hyperaldosteronism
11β-HSD deficiency (→ lack of inactivation of cortisol, which binds to nonselective mineralocorticoid receptor)
Black licorice (glycyrrhizinic acid inhibits 11β-HSD), extreme hypercortisolism (overwhelming 11β-HSD), exogenous mineralocorticoids
Liddle’s syndrome (constitutively activated/overexpressed distal tubular renal Na channel)

Clinical manifestations


Mild to moderate HTN
(11% of Pts w/ HTN refractory to 3 drugs;
Lancet
2008;371:1921), headache, muscle weakness, polyuria, polydipsia; no peripheral edema because of “escape” from Na retention; malignant HTN is rare
• Classically
hypokalemia
(but often normal), metabolic alkalosis, mild hypernatremia

Diagnostic studies

• 5–10% of Pts w/ HTN; ∴ screen if HTN + hypokalemia, adrenal mass or refractory HTN
• Screening:
aldo
(>15–20 ng/dL)
and
plasma aldo
:
renin ratio
(>20 if 1°) obtain 8 a.m. paired values (
off
spironolactone & eplerenone for 6 wk); Se & Sp >85%
• ACEI/ARB, diuretics, CCB can ↑ renin activity → ↓ PAC/PRA ratio and βBs may ↑ PAC/PRA ratio;∴ avoid. ɑ-blockers generally best to control HTN during dx testing.
• Confirm with
sodium suppression test
(fail to suppress aldo after sodium load) oral salt load (+ KCl) × 3 d, ✓ 24-h urine (
if aldo >12 µg/d while Na >200 mEq/d)
or
2L NS over 4 h, measure aldo at end of infusion (
if aldo >5 ng/dL)
Figure 7-4 
Approach to suspected hyperaldosteronism

Treatment

• Adenoma → adrenalectomy vs. medical Rx w/ spironolactone or eplerenone
• Carcinoma → adrenalectomy
• Hyperplasia → spironolactone or eplerenone; GRA → glucocorticoids ± spironolactone

ADRENAL INSUFFICIENCY

Etiologies


Primary
= adrenocortical disease =
Addison’s disease
autoimmune
: isolated or in assoc w/ PGA syndromes (see table on page 7-2)
infection
: TB, CMV, histoplasmosis
vascular
: hemorrhage (usually in setting of sepsis), thrombosis, HIT and trauma
metastatic disease
: (90% of adrenals must be destroyed to cause insufficiency)
deposition diseases
: hemochromatosis, amyloidosis, sarcoidosis
drugs
: ketoconazole, etomidate (even after single dose), rifampin, anticonvulsants

Secondary
= pituitary failure of ACTH secretion (but aldosterone
intact
b/c RAA axis) any cause of primary or secondary hypopituitarism (see “Pituitary Disorders”)
glucocorticoid therapy (can occur after ≥2 wk of “suppressive doses”; dose effect variable; <10 mg prednisone daily chronically can be suppressive)
megestrol (a progestin with some glucocorticoid activity)

Clinical manifestations
(
NEJM
1996;335:1206)

Primary
or
secondary
:
weakness and fatigability
(99%),
anorexia
(99%),
orthostatic hypotension
(90%), nausea (86%), vomiting (75%), hyponatremia (88%) •
Primary only
(extra s/s due to lack of aldosterone and ↑ ACTH): marked
orthostatic hypotension
(because volume-depleted), salt craving,
hyperpigmentation
(seen in creases, mucous membranes, pressure areas, nipples),
hyperkalemia

Secondary only
: ± other manifestations of hypopituitarism (see “Pituitary Disorders”)
Diagnostic studies
(
Annals
2003;139:194)
• Early a.m. serum cortisol: <3 µg/dL virtually diagnostic; ≥18 µg/dL rules it out (except in severe septic shock—see below) • Standard (250 µg)
cosyntropin stimulation test
(testing ability of ACTH → ↑ cortisol)

normal = 60-min post-ACTH cortisol ≥18 µg/dL
abnormal in
primary
b/c adrenal gland diseased and unable to give adequate output
abnormal in
chronic
secondary b/c adrenals atrophied and unable to respond
(very rarely, may be
normal
in
acute secondary
b/c adrenals still able to respond; early a.m. cortisol can be used rather than post-stim value in these cases)
• Other tests to evaluate HPA axis (w/ guidance by endocrinologist): insulin-induced
hypoglycemia (measure serum cortisol response); metyrapone (blocks cortisol synthesis
and therefore stimulates ACTH, measure plasma 11-deoxycortisol and urinary
17-hydroxycorticosteroid levels)
• Other lab abnormalities: hypoglycemia, eosinophilia, lymphocytosis, ± neutropenia • ACTH: ↑ in 1°, ↓ or low-normal in 2°
• Imaging studies to consider
pituitary MRI to detect anatomical abnormalities
adrenal CT: small, noncalcified adrenals in autoimmune, enlarged in metastatic disease, hemorrhage, infection or deposition (although they may be normal-appearing)

Adrenal insufficiency & critical illness
(
NEJM
2003;348:727;  
JAMA
2009;301:2362)
• ↑ circulating cortisol despite ↓ ACTH due to ↓ clearance and possibly stimulation by cytokines; ∴ dx of adrenal insufficiency problematic (
NEJM
2013;368:1477) • Nonetheless, reasonable to perform ACTH stim ASAP in hypotensive Pt suspected to have absolute adrenal insuffic.

• Initiate corticosteroids early: use dexamethasone 2–4 mg IV q6h + fludrocortisone 50 µg daily prior to ACTH stim; change to hydrocortisone 50–100 mg IV q6–8h once test completed.
• Rx of
relative adrenal insufficiency
controversial (see “Sepsis”)
Treatment

Acute
insufficiency: volume resuscitation w/ normal saline +
hydrocortisone IV
as above •
Chronic
insufficiency
Hydrocortisone: 20–30 mg PO qd (2⁄3 a.m. 1⁄3 early p.m.) or prednisone ~5 mg PO qam
Fludrocortisone (
not
needed in 2° adrenal insufficiency): 0.05–0.1 mg PO qam
backup dexamethasone 4-mg IM prefilled syringe given to Pt for emergency situations

PHEOCHROMOCYTOMA

Clinical manifestations (five Ps)


Pressure
(hypertension, paroxysmal in 50%, severe & resistant to Rx, occ orthostatic)

Pain
(headache, chest pain)

Palpitations
(tachycardia, tremor, wt loss, fever)

Perspiration
(profuse)

Pallor
(vasoconstrictive spell)
• “Rule of 10”: 10% extra-adrenal (known as paraganglioma), 10% in children,
10% multiple or bilateral, 10% recur (↑ in paraganglioma), 10% malignant (↑ in
paraganglioma), 10% familial, 10% incidentaloma
• Emotional stress does not trigger paroxysms, but abdominal manipulation can trigger
catecholamine release; some reports of IV contrast causing paroxysms
• Associated with MEN2A/2B, von Hippel Lindau, neurofibromatosis type 1, familial
paraganglioma (mutations in succinate dehydrogenase gene B, C and D)

Diagnostic studies

• 24° urinary fractionated metanephrines & catechols: 90% Se, 98% Sp (
JCEM
2003;88:553). Screening test of choice if low-risk (as false
with severe illness, renal failure, OSA, labetalol due to assay interference, TCAs, medications containing sympathomimetics).
• Plasma free metanephrines: 99% Se, 89% Sp (
JAMA
2002;287:1427). Screening test of choice if high risk, but ↑ rate of false
in low-preval. population.

Other books

Pickle Puss by Patricia Reilly Giff
You Have Seven Messages by Stewart Lewis
Ulysses S. Grant by Michael Korda
The Doomsday Vault by Steven Harper
Father of the Man by Stephen Benatar